Introduction
Gentian violet, a topical antiseptic and antifungal agent, is widely used in medical and veterinary practices. This article will delve into the market analysis and price projections for gentian violet, focusing on its current market dynamics, pricing trends, and future outlook.
Market Dynamics
Current Market Status
Gentian violet is available in various formulations, including solutions and swabs. The drug is manufactured by several companies, with The Podiatree Company being one of the notable vendors[1].
Demand and Usage
The demand for gentian violet is driven by its efficacy in treating fungal and bacterial infections. It is commonly used in dermatology, podiatry, and veterinary medicine. The consistent demand across these sectors ensures a stable market presence.
Pricing Trends
Historical Pricing
Recent data indicates that the price of gentian violet 1% solution has remained relatively stable over the past year. For example, the price per milliliter (ml) of gentian violet 1% solution with the NDC 24385-0003-46 has fluctuated minimally between $0.04949 and $0.04951 per ml from September 2024 to December 2024[1].
Comparative Pricing
When comparing prices from different vendors, it is evident that prices can vary. For instance, The Podiatree Company's 2% gentian violet solution (NDC 54633-0014-02) had a price per ml ranging from $0.14746 to $0.16356 over different periods[1].
Factors Influencing Pricing
Regulatory Environment
Drug prices can be influenced by regulatory changes and compliance requirements. For example, the FDA's National Drug Code (NDC) Directory ensures that all drug products, including gentian violet, are properly listed and tracked, which can impact pricing transparency and stability[4].
Market Competition
The presence of multiple manufacturers and vendors contributes to competitive pricing. However, gentian violet is not a highly competitive market compared to other pharmaceuticals, which can lead to more stable prices.
Economic Factors
General economic conditions, such as inflation and production costs, can affect drug prices. According to recent studies, many prescription drugs have seen significant price increases, often exceeding the rate of inflation. However, gentian violet prices have not followed this trend, remaining relatively stable[2].
Price Projections
Short-Term Projections
Given the stable historical pricing and the lack of significant market disruptions, it is likely that the price of gentian violet will remain relatively stable in the short term. Any changes are expected to be minimal and reflective of minor adjustments in production costs or market conditions.
Long-Term Projections
In the long term, the price of gentian violet may be influenced by broader market trends and regulatory changes. However, since gentian violet is a well-established drug with a stable demand, significant price fluctuations are unlikely.
Impact of Pricing on Affordability and Access
Affordability
The stable and relatively low price of gentian violet makes it an affordable option for patients and healthcare providers. This affordability is crucial, especially for treatments that require repeated use or long-term administration.
Access
The availability of gentian violet at a stable price ensures that it remains accessible to a wide range of users, including those in resource-limited settings. This accessibility is a key factor in its continued use across various medical disciplines.
Conclusion
Gentian violet, with its NDC 24385-0003, operates in a stable market environment characterized by consistent demand and relatively stable pricing. The factors influencing its pricing, such as regulatory compliance and market competition, suggest that prices will remain stable in both the short and long term.
Key Takeaways
- Stable Pricing: Gentian violet prices have remained relatively stable over recent years.
- Consistent Demand: The drug's efficacy in treating fungal and bacterial infections ensures a stable market presence.
- Regulatory Compliance: FDA regulations, such as the NDC Directory, contribute to pricing transparency and stability.
- Affordability: The low and stable price of gentian violet makes it an affordable treatment option.
- Access: The drug's accessibility is ensured by its stable price and widespread availability.
FAQs
What is the current price of gentian violet 1% solution with NDC 24385-0003-46?
The current price of gentian violet 1% solution with NDC 24385-0003-46 is approximately $0.04950 per ml as of December 2024[1].
How does the price of gentian violet compare to other antiseptic solutions?
The price of gentian violet is generally lower than many other antiseptic solutions, making it a cost-effective option for patients and healthcare providers.
What factors influence the price of gentian violet?
The price of gentian violet is influenced by factors such as production costs, market competition, and regulatory compliance.
Is gentian violet widely available?
Yes, gentian violet is widely available due to its stable demand and multiple manufacturers.
Are there any regulatory changes that could impact the price of gentian violet?
While there are no immediate regulatory changes anticipated, any future changes in FDA regulations or compliance requirements could potentially impact pricing.
Sources
- DrugPatentWatch - Pharmaceutical drug prices and trends for GENTIAN VIOLET.
- ASPE - Changes in the List Prices of Prescription Drugs, 2017-2023.
- Drug Development & Delivery - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
- FDA - National Drug Code Directory.
- HRSA - NDC Product Details - Log into 340B OPAIS.
